A lawsuit challenges the FDA's decision to remove semaglutide from the shortage list, alleging it was arbitrary and harms ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

It's the second year in a row that Lilly has used the Oscars as a platform to drive home a message about GLP-1-based obesity ...

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s ...

The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.

Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...

California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.

Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...